Preeclampsia induced by human sFLT1 increases susceptibility to diet-induced metabolic syndrome in male mouse offspring
- 1Department of Gynecology and Obstetrics, University Hospital Essen
- 2Genomics and Transcriptomics Facility, Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen
- 3Department of Pediatrics, Neonatology & Experimental perinatal Neurosciences; Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen
Abstract
The pregnancy disorder preeclampsia (PE) is characterized by hypertension and an increase in anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1), a clinical biomarker for PE diagnosis. PE is often accompanied by fetal growth restriction (FGR) and predisposes offspring to programming of diseases in adulthood. It remains unclear whether anti-angiogenesis, independent of FGR, contributes to postnatal metabolic programming. Using a transgenic mouse model, we simulated PE/FGR by systemic human sFLT1 (hsFLT1) overexpression. This allowed us to differentiate the effects of PE from FGR-related consequences by comparison to an FGR-only control group. Further, challenging the offspring after weaning with a high-caloric Western-style diet (WD) compared to a standard diet (SD) revealed PE-specific metabolic programming predominantly in males. Under SD conditions, PE males exhibited increased hepatic AKT and ERK signaling and lacked significant weight gain. PE SD males showed elevated RNA expression of leptin-sensitive Pomc and Slc16a8 in the hypothalamus, suggesting increased leptin sensitivity under these conditions. Only PE WD males developed a metabolic syndrome (obesity, glucose intolerance, elevated serum leptin and triglyceride levels). Furthermore, PE WD males exhibited inflammatory liver damage as evidenced by increased serum alanine aminotransferase (ALT) and hepatic tumor necrosis factor alpha (TNFα) protein levels. Bulk liver RNA sequencing revealed increased inflammation and dysregulated metabolism. The microbiome and stress (serum corticosterone) were excluded as confounders in PE-specific fetal programming. This study highlights the increased risk of male offspring developing a diet-induced metabolic syndrome after hsFLT1 exposure during preeclampsia.
Related
- Weight Gain During Successful Tuberculosis Treatment Increases the Risk of Post-tuberculosis Metabolic Syndrome.
- Metabolic syndrome, genetic susceptibility, and risk of cardiovascular disease: a prospective study in the UK Biobank
- Chronic environmental cold stress increases migraine susceptibility associated with regional dysregulation of RBFOX1 and PTPRD in the somatosensory network
- Gestational Low Protein Diet Increases the Susceptibility to N-Bis(2-Hydroxypropyl)nitrosamine-Induced Lung Tumors in Female Wistar Rats.
- R278H Substitution Reduces Mouse Tyrosine Hydroxylase Activity and Increases Susceptibility to Catechol Inhibition
BibTeX
@article{edinger2026preeclampsia,
title = {{Preeclampsia induced by human sFLT1 increases susceptibility to diet-induced metabolic syndrome in male mouse offspring}},
author = {Alina Edinger and Elisa Marie Elfroth and Bettina Budeus and Lisa Hübner and Melanie Seibel and Rebecca Steffen and Meray Serdar and Rainer Kimmig and Ursula Felderhoff-Müser and Ivo Bendix and Alexandra Gellhaus},
journal = {Frontiers in Endocrinology},
year = {2026},
month = nov,
doi = {10.3389/fendo.2026.1994304},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1994304/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Preeclampsia induced by human sFLT1 increases susceptibility to diet-induced metabolic syndrome in male mouse offspring
AU - Alina Edinger
AU - Elisa Marie Elfroth
AU - Bettina Budeus
AU - Lisa Hübner
AU - Melanie Seibel
AU - Rebecca Steffen
AU - Meray Serdar
AU - Rainer Kimmig
AU - Ursula Felderhoff-Müser
AU - Ivo Bendix
AU - Alexandra Gellhaus
PY - 2026
DA - 2026/11/16
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1994304
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1994304/full
AB - The pregnancy disorder preeclampsia (PE) is characterized by hypertension and an increase in anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1), a clinical biomarker for PE diagnosis. PE is often accompanied by fetal growth restriction (FGR) and predisposes offspring to programming of diseases in adulthood. It remains unclear whether anti-angiogenesis, independent of FGR, contributes to postnatal metabolic programming. Using a transgenic mouse model, we simulated PE/FGR by systemic human sFLT1 (hsFLT1) overexpression. This allowed us to differentiate the effects of PE from FGR-related consequences by comparison to an FGR-only control group. Further, challenging the offspring after weaning with a high-caloric Western-style diet (WD) compared to a standard diet (SD) revealed PE-specific metabolic programming predominantly in males. Under SD conditions, PE males exhibited increased hepatic AKT and ERK signaling and lacked significant weight gain. PE SD males showed elevated RNA expression of leptin-sensitive Pomc and Slc16a8 in the hypothalamus, suggesting increased leptin sensitivity under these conditions. Only PE WD males developed a metabolic syndrome (obesity, glucose intolerance, elevated serum leptin and triglyceride levels). Furthermore, PE WD males exhibited inflammatory liver damage as evidenced by increased serum alanine aminotransferase (ALT) and hepatic tumor necrosis factor alpha (TNFα) protein levels. Bulk liver RNA sequencing revealed increased inflammation and dysregulated metabolism. The microbiome and stress (serum corticosterone) were excluded as confounders in PE-specific fetal programming. This study highlights the increased risk of male offspring developing a diet-induced metabolic syndrome after hsFLT1 exposure during preeclampsia.
SN - 1664-2392
ER -